Strategic Investment Solutions, Inc. /Il Revance Therapeutics, Inc. Transaction History
Strategic Investment Solutions, Inc. /Il
- $576 Billion
- Q4 2023
A detailed history of Strategic Investment Solutions, Inc. /Il transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Strategic Investment Solutions, Inc. /Il holds 150 shares of RVNC stock, worth $385. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 3,150
95.24%
Holding current value
$385
Previous $60.6 Million
97.82%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RVNC
# of Institutions
211Shares Held
83.5MCall Options Held
656KPut Options Held
424K-
Capital World Investors Los Angeles, CA13.9MShares$35.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.31MShares$18.8 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA6.28MShares$16.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$13.9 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.25MShares$13.5 Million3.02% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...